The DoD/CIO office knows it has a problem protecting our
The DoD/CIO office knows it has a problem protecting our troops mobile devices. Lt/ Gen Ben Hodges made it public in an Army Times interview during Field Ex Anaconda in Poland. SFOR IP was evaluated by DISA and used in a DoD contractor's day long exercise in D.C. the following summer. Bo Ditel of ACS (now CSI) facilitated. CROMTEC-CSI got the initial $50K DoD/SBIR phase one grant. Then the follow on two million dollar DoD/SBIR phase two grant.
That ended in Aug'19. CSI has yet to provide test results of that EPL evaluation of SFOR KTLS level OOB/MFA. You wonder why Mark did not have CSI play a key vendor role with SafeVChat?
CSI dropped the DoD ball! Our troops still need to have their (U) mobile devices protected!
1
Zerify Inc (ZRFY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Next PR Launches Innovative AI Optimization Services Next PR, an award-winning public relations firm, has recently introduced its AI Optimization Services, aimed at helping brands maintain visibility and authority in today's AI-driven digital landscape. As companies strive to adapt to the ever-changing world of artificial intelligence and search engine results generated...
Continue Reading
Overview of the Security and Vulnerability Management Market The Security and Vulnerability Management Market is on an impressive trajectory, predicted to expand from USD 17.55 billion to USD 24.07 billion by 2030, reflecting significant growth propelled by rising global vulnerabilities. Market Growth Drivers Multiple factors are contributing to this market's growth....
Continue Reading
Introducing Bybit.eu: A New Era for European Crypto Users Bybit, a leader in the cryptocurrency exchange market and the world's second-largest by trading volume, is evolving by launching Bybit.eu. This fully MiCAR-compliant platform is crafted specifically for users across the European Economic Area (EEA). Bybit EU GmbH operates this platform as a licensed Crypto-Asset...
Continue Reading
Nuvectis Pharma Reports Significant NXP900 Findings Nuvectis Pharma, Inc. (NASDAQ: NVCT), known for its pioneering work in oncology, has shared key insights regarding NXP900 at a recent prestigious cancer research meeting. This innovative drug shows considerable promise in treating advanced cancers. Based on a Phase 1a dose-escalation study, NXP900 demonstrated strong...
Continue Reading
The Unexpected Christmas Quest of Elon Musk Christmas is a time when many cherish the joy of giving and receiving gifts. However, when you are someone like Elon Musk, a dynamic CEO known for pushing boundaries with Tesla and SpaceX, a forgotten gift can turn into an extraordinary adventure. Imagine waking on Christmas Eve only to realize that you forgot to buy your...
Continue Reading
